| |
| |
|
| Insider
Information: |
Blackman Samuel C. |
| Relationship: |
|
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
1,174,662 |
|
|
Indirect Shares
|
1,000,000 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
2,174,662 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Day One Biopharmaceuticals, Inc. |
DAWN |
|
2024-04-18 |
1,174,662 |
2024-04-18 |
1,000,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DAWN |
Day One Biopharmaceutical... |
HEAD OF R&D |
• – – |
2024-04-18 |
4 |
AS |
$16.02 |
$160,163 |
D/D |
(10,000) |
1,174,662 |
0 |
- |
|
| DAWN |
Day One Biopharmaceutical... |
HEAD OF R&D |
• – – |
2024-03-25 |
4 |
AS |
$16.01 |
$160,055 |
D/D |
(10,000) |
1,184,662 |
0 |
- |
|
| DAWN |
Day One Biopharmaceutical... |
HEAD OF R&D |
• – – |
2024-03-11 |
4 |
AS |
$15.24 |
$457,314 |
D/D |
(30,000) |
1,194,662 |
0 |
- |
|
| DAWN |
Day One Biopharmaceutical... |
HEAD OF R&D |
• – – |
2024-02-27 |
4 |
AS |
$16.11 |
$322,166 |
D/D |
(20,000) |
1,224,662 |
0 |
- |
|
| DAWN |
Day One Biopharmaceutical... |
HEAD OF RESEARCH AND DEVELOPME |
• – – |
2024-02-16 |
4 |
S |
$15.25 |
$34,430 |
D/D |
(2,258) |
1,244,662 |
0 |
- |
|
| DAWN |
Day One Biopharmaceutical... |
HEAD OF RESEARCH AND DEVELOPME |
• – – |
2024-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,686 |
1,246,920 |
0 |
- |
|
| DAWN |
Day One Biopharmaceutical... |
Head of Research and Developme |
• – – |
2023-11-16 |
4 |
S |
$11.69 |
$8,288 |
D/D |
(709) |
1,238,234 |
0 |
- |
|
| DAWN |
Day One Biopharmaceutical... |
Head of Research and Developme |
• – – |
2023-11-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,624 |
1,238,943 |
0 |
- |
|
| DAWN |
Day One Biopharmaceutical... |
Head of Research and Developme |
• – – |
2023-08-17 |
4 |
S |
$13.86 |
$9,258 |
D/D |
(668) |
1,236,319 |
0 |
- |
|
| DAWN |
Day One Biopharmaceutical... |
Head of Research and Developme |
• – – |
2023-08-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,624 |
1,236,987 |
0 |
- |
|
| DAWN |
Day One Biopharmaceutical... |
Chief Medical Officer |
• – – |
2023-06-05 |
4 |
AS |
$16.00 |
$19,664 |
D/D |
(1,229) |
1,234,363 |
0 |
- |
|
| DAWN |
Day One Biopharmaceutical... |
Chief Medical Officer |
• – – |
2023-05-16 |
4 |
S |
$13.12 |
$9,081 |
D/D |
(692) |
1,235,592 |
0 |
- |
|
| DAWN |
Day One Biopharmaceutical... |
Chief Medical Officer |
• – – |
2023-05-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,624 |
1,236,284 |
0 |
- |
|
| DAWN |
Day One Biopharmaceutical... |
Chief Medical Officer |
• – – |
2023-03-10 |
4 |
AS |
$18.05 |
$180,484 |
D/D |
(10,000) |
1,233,660 |
0 |
- |
|
| DAWN |
Day One Biopharmaceutical... |
Chief Medical Officer |
• – – |
2023-02-16 |
4 |
S |
$19.57 |
$13,192 |
D/D |
(674) |
1,243,660 |
0 |
- |
|
| DAWN |
Day One Biopharmaceutical... |
Chief Medical Officer |
• – – |
2023-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,624 |
1,244,334 |
0 |
- |
|
| DAWN |
Day One Biopharmaceutical... |
Chief Medical Officer |
• – – |
2023-02-10 |
4 |
AS |
$20.07 |
$200,659 |
D/D |
(10,000) |
1,241,710 |
0 |
- |
|
| DAWN |
Day One Biopharmaceutical... |
Chief Medical Officer |
• – – |
2023-01-10 |
4 |
AS |
$22.75 |
$228,644 |
D/D |
(10,000) |
1,250,148 |
0 |
- |
|
| DAWN |
Day One Biopharmaceutical... |
Chief Medical Officer |
• – – |
2022-12-01 |
4 |
AS |
$21.38 |
$214,530 |
D/D |
(10,000) |
1,260,148 |
0 |
- |
|
| DAWN |
Day One Biopharmaceutical... |
Chief Medical Officer |
• – – |
2022-11-16 |
4 |
S |
$21.46 |
$8,090 |
D/D |
(377) |
1,270,148 |
0 |
- |
|
| DAWN |
Day One Biopharmaceutical... |
Chief Medical Officer |
• – – |
2022-11-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,187 |
1,270,525 |
0 |
- |
|
| DAWN |
Day One Biopharmaceutical... |
Chief Medical Officer |
• – – |
2022-11-01 |
4 |
AS |
$20.01 |
$200,050 |
D/D |
(10,000) |
1,269,338 |
0 |
- |
|
| DAWN |
Day One Biopharmaceutical... |
Chief Medical Officer |
• – – |
2022-10-03 |
4 |
AS |
$19.99 |
$199,852 |
D/D |
(10,000) |
1,279,338 |
0 |
- |
|
| DAWN |
Day One Biopharmaceutical... |
Chief Medical Officer |
• – – |
2022-09-01 |
4 |
AS |
$23.14 |
$232,452 |
D/D |
(10,000) |
1,289,338 |
0 |
- |
|
| DAWN |
Day One Biopharmaceutical... |
Chief Medical Officer |
• – – |
2022-08-16 |
4 |
S |
$24.31 |
$22,876 |
D/D |
(941) |
1,299,338 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
